| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/09/1997 | WO1997016463A1 Polymers comprising reversible hydrophobic functionalities |
| 05/09/1997 | WO1997016204A1 Continuous low-dose cytokine infusion therapy |
| 05/09/1997 | WO1997016196A1 Improved process and composition for therapeutic cisplatin (cddp) |
| 05/09/1997 | WO1997016178A1 Stabilised pharmaceutical preparations containing thyroid hormone |
| 05/09/1997 | WO1997016174A1 Process for aqueous granulation of clarithromycin |
| 05/09/1997 | WO1997016173A1 New technology for wet granulation |
| 05/09/1997 | WO1997016172A1 Controlled release formulation (albuterol) |
| 05/09/1997 | WO1997016166A1 Skin care preparation and method |
| 05/09/1997 | CA2236175A1 New technology for wet granulation |
| 05/07/1997 | EP0771832A2 Blends of absorbable polyoxaesters containing amines and/or amido groups |
| 05/07/1997 | EP0771559A1 Cosmetic and pharmaceutical emulsions |
| 05/07/1997 | EP0771558A1 Cosmetic and pharmaceutical emulsions |
| 05/07/1997 | EP0771339A1 Moisture barrier film coating composition, method, and coated form |
| 05/07/1997 | EP0771217A1 Solid drug forms containing clathrates of steroid sex hormones |
| 05/07/1997 | EP0771216A1 Methods and compositions for the specific coagulation of vasculature |
| 05/07/1997 | EP0771209A2 Novel peptides |
| 05/07/1997 | EP0771208A1 Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells |
| 05/07/1997 | EP0771190A1 Lock and key micelles |
| 05/07/1997 | EP0686024B1 Thickening mixture based on guar gum or non-ionic cellulose and a cross-linked polymer, and cosmetic or dermatological hair- or skin-care composition containing said mixture |
| 05/07/1997 | EP0662820B1 Compositions for treatmewnt of inflamed tissues |
| 05/07/1997 | EP0660676B1 Novel compositions |
| 05/07/1997 | EP0652774B1 Pharmaceutical composition for topical use containing a crosslinked cationic polymer and an alkoxylated ether |
| 05/07/1997 | EP0587659B1 Pharmaceutical carrier |
| 05/07/1997 | EP0542969B1 Biodegradable particulate vector and method of synthesis |
| 05/07/1997 | EP0419563B1 Time release protein |
| 05/07/1997 | DE19541326A1 Wasserlösliche oder wasserdispergierbare Polyurethane mit endständigen Säuregruppen, ihre Herstellung und ihre Verwendung Water-soluble or water-dispersible polyurethanes having terminal acid groups, their preparation and their use |
| 05/07/1997 | DE19541260A1 Therapeutische Zubereitung zur transdermalen Applikation von Wirkstoffen durch die Haut Therapeutic composition for transdermal administration of drugs through the skin |
| 05/07/1997 | CA2189520A1 Blends of absorbable polyoxaesters containing amines and/or amido groups |
| 05/06/1997 | US5627233 Biocompatability |
| 05/06/1997 | US5627163 Treatment of traveller's diarrhea |
| 05/06/1997 | US5627158 Antisense oligonucleotides of human regulatory subunit RI-.sub.α of camp dependent protein kinases for the treatment of cancer |
| 05/06/1997 | US5627043 Production of proteins with dibasic amino acids and cleavage |
| 05/06/1997 | US5626875 Stabilized galenic formulations comprising an acid labile benzimidazole compound and its preparation |
| 05/06/1997 | US5626873 Emulsions |
| 05/06/1997 | US5626870 Accurately controlled particle size |
| 05/06/1997 | US5626869 Pharmaceutical composition containing a defined lipid system |
| 05/06/1997 | US5626868 Amphoteric and nonionic surfactants with lipid vesicles |
| 05/06/1997 | US5626867 Liposome for cytotoxic agents |
| 05/06/1997 | US5626864 Preparation of colloidal aqueous solutions of active substances of low solubility |
| 05/06/1997 | US5626863 Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
| 05/06/1997 | US5626862 Drug delivery from polymer matrices by release from matrix by degradation of polymer |
| 05/06/1997 | US5626856 Cosmetic delivery vehicles and related compositions |
| 05/02/1997 | EP0770627A1 Composition and methods using nitroxides to avoid oxygen toxicity |
| 05/02/1997 | EP0770399A2 Additives enhancing topical actions of therapeutic agents |
| 05/02/1997 | EP0770390A1 Nasally administrable compositions containing physiologically active peptides |
| 05/02/1997 | EP0770384A1 Solid, anhydrous, pharmaceutical compositions for vaginal use |
| 05/02/1997 | EP0770382A1 Cosmetic and/or pharmaceutical emulsions |
| 05/02/1997 | EP0770381A1 Support and composition containing it together with a stabilised cosmetic or dermatologic agent |
| 05/02/1997 | EP0770378A1 Cosmetic preparations with an effective amount of glycosylglycerides |
| 05/02/1997 | EP0770140A1 Nucleic acid containing composition, preparation and uses of same |
| 05/02/1997 | EP0770133A1 Adenovirus comprising a gene coding for an no synthase |
| 05/02/1997 | EP0769967A1 Compounds, pharmaceutical composition and diagnostic device comprising same and their use |
| 05/02/1997 | EP0769966A1 Biotin compounds for targetting tumors and sites of infection |
| 05/02/1997 | EP0769965A1 Aqueous risperidone formulations |
| 05/02/1997 | EP0769960A1 Pharmaceutical compositions containing a bile salt and a buffer for increased bioavailability of an active compound |
| 05/02/1997 | EP0769955A1 Non-antigenic amine derived polymers and polymer conjugates |
| 05/02/1997 | EP0769953A1 Pharmaceutical compositions comprising co-dried sucralfate gel and polyalcohol |
| 05/02/1997 | EP0769951A1 Long-acting oxytetracycline composition |
| 05/02/1997 | EP0769948A1 Pharmaceutical composition for the controlled release of moguisteine in a liquid suspension |
| 05/02/1997 | EP0769942A1 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug |
| 05/02/1997 | EP0769936A1 Self-emulsifying drug delivery system |
| 05/02/1997 | EP0623024B1 Pharmaceutical bacteriocin compositions and their use for treating gastrointestinal disorders |
| 05/02/1997 | EP0544000B1 N-acetylcarboxymethylchitosan derivative and production thereof |
| 05/01/1997 | WO1997015680A1 Cationic polyacrylates and poly(alkyl) acrylates or the corresponding acrylamides for use in synthetic transfection or blocking systems |
| 05/01/1997 | WO1997015668A2 Methods and compositions comprising glut-2 and glut-2 chimeras |
| 05/01/1997 | WO1997015661A1 Microporous pathogen-killing composition |
| 05/01/1997 | WO1997015655A2 New artificial tissue, method for the production and the use thereof |
| 05/01/1997 | WO1997015389A1 Preparation of peptide containing biodegradable microspheres by melt process |
| 05/01/1997 | WO1997015331A1 Methods of preserving microorganisms |
| 05/01/1997 | WO1997015330A1 Hyaluronic acid as dna carrier for gene therapy and vegf antisense dna to treat abnormal retinal vascularization |
| 05/01/1997 | WO1997015329A1 Stabilised pharmaceutical compositions containing dobutamine |
| 05/01/1997 | WO1997015328A1 Pharmaceutical compositions containing platelet aggregation inhibitors |
| 05/01/1997 | WO1997015325A1 Pseudomonas exotoxin as immunogenic carrier in synthetic conjugate vaccines |
| 05/01/1997 | WO1997015317A1 GnRH/REDUCED PSEUDOMONAS EXOTOXIN CONJUGATES |
| 05/01/1997 | WO1997015314A1 Vaginal pharmaceutical compositions containing a peroxide source |
| 05/01/1997 | WO1997015307A1 Eye drops |
| 05/01/1997 | WO1997015306A1 Infusions of neuroprotectants and perfluorochemicals |
| 05/01/1997 | WO1997015295A1 Composition for transdermal delivery |
| 05/01/1997 | WO1997015288A2 Method and preparations for stabilizing biological materials by drying methods without freezing |
| 05/01/1997 | WO1997015287A1 Thermosensitive biodegradable polymers based on poly(ether-ester) block copolymers |
| 05/01/1997 | WO1997015286A1 Method of treating wounds with a gel composition |
| 05/01/1997 | WO1997015285A1 Non-polymeric sustained release delivery system |
| 05/01/1997 | WO1997015283A1 Topical compositions containing n-acetylcysteine and odor masking materials |
| 05/01/1997 | WO1997015269A2 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| 05/01/1997 | WO1997015195A1 Hybrid matrix implants and explants |
| 05/01/1997 | WO1997015191A1 Wet granulation formulation of a growth hormone secretagogue |
| 05/01/1997 | WO1997012601A3 Gel formulations containing growth factors |
| 05/01/1997 | CA2235685A1 Hyaluronic acid as dna carrier for gene therapy and vegf antisense dna to treat abnormal retinal vascularization |
| 05/01/1997 | CA2235614A1 Eye drops |
| 05/01/1997 | CA2235602A1 Preparation of peptide containing biodegradable microspheres by melt process |
| 05/01/1997 | CA2235510A1 Gnrh/reduced pseudomonas exotoxin conjugates |
| 05/01/1997 | CA2235495A1 Methods of preserving microorganisms |
| 05/01/1997 | CA2234817A1 Wet granulation formulation of a growth hormone secretagogue |
| 05/01/1997 | CA2233882A1 Pseudomonas exotoxin as immunogenic carrier in synthetic conjugate vaccines |
| 05/01/1997 | CA2232419A1 Stabilised pharmaceutical compositions containing dobutamine |
| 05/01/1997 | CA2205534A1 Method, compositions and kits for increasing the bioavailability of pharmaceutical agents |
| 04/30/1997 | DE19541128A1 Stabilisierte schilddrüsenhormonhaltige Arzneimittel Stabilized thyroid hormone-containing drugs |
| 04/30/1997 | DE19540132A1 Stable lyophilisate of ifosfamide containing lactose as auxiliary material |
| 04/30/1997 | DE19539574A1 Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren Compositions and methods for stabilizing biological materials by means of drying processes without freezing |
| 04/30/1997 | CN1148814A Method of mfg. and storing solutions |